| abstract |
The present invention provides a combination or multivalent vaccine comprising an acellular vaccine component and use thereof. (A) Purified pertussis toxoid, linear hemagglutinin, pertactin, agglutinogen, (b) tetanus toxoid, (c) diphtheria toxoid, (d) tetanus toxoid, diphtheria toxoid, Haemophilus influenzae type b Pertussis, which is composed of a complex of carrier molecules selected from capsular polysaccharides of which each component of the formulation is adjusted so that the immunogenicity of each component is not impaired by other individual components in the formulation A multivalent immunogenic component that provides in-host defense against diseases caused by infection with Bordetella pertussis, Clostridium tetani, Corynebacterium diphtheriae, and / or Haemophilus influenzae. [Selection figure] None |